Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

B-CLL

AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-κB survival pathway

Abstract

Clinical treatment of B-cell chronic lymphocytic leukemia (B-CLL) is limited by the progressive drug resistance and nonselectivity of most drugs towards malignant cells. Depsipeptides are present in certain bacteria and display potent antitumor activity. We have studied the effect of the novel cyclodepsipeptide AT514 (serratamolide) from Serratia marcescens on B-CLL cell viability. AT514 induced apoptosis of B-CLL cells from the 21 patients studied, as confirmed by Annexin-V binding and nuclei condensation, with an average IC50 of 13 μ M. AT514 was effective in those B-CLL cases resistant to fludarabine, but had no effect on normal PBL. AT514 preferentially activated the intrinsic apoptotic pathway, as evidenced by loss of mitochondrial membrane potential, release of cytochrome c and activation of caspase-9 and -3, but not of caspase-8. Importantly, AT514 interfered with phosphatidylinositol-3 kinase and protein kinase C survival signals since it increased the apoptotic effect of LY294002 and BisI inhibitors, and induced Akt dephosphorylation at Ser 473. AT514 also decreased NF-κB activity by dramatically reducing the levels of p65 in B-CLL. This was confirmed on functional assays using NF-κB-luc-transfected Raji cells and transgenic mice. Our results establish that AT514 induces apoptosis of primary B-CLL cells and could be useful for clinical treatment of this malignancy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Kroft SH, Finn WG, Peterson LC . The pathology of the chronic lymphoid leukaemias. Blood Rev 1995; 9: 234–250.

    Article  CAS  PubMed  Google Scholar 

  2. Bannerji R, Byrd JC . Update on the biology of chronic lymphocytic leukemia. Curr Opin Oncol 1998; 12: 22–29.

    Article  Google Scholar 

  3. Jewell AP . Role of apoptosis in the pathogenesis of B-cell chronic lymphocytic leukaemia. Br J Biomed Sci 2002; 59: 235–238.

    Article  PubMed  Google Scholar 

  4. Barragán M, Bellosillo B, Campas C, Colomer D, Pons G, Gil J . Involvement of protein kinase C and phosphatidyl-inositol 3-kinase pathways in the survival of chronic lymphocytic leukemia cells. Blood 2002; 99: 2969–2976.

    Article  PubMed  Google Scholar 

  5. Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C et al. Constitutively activated phosphatidyl-inositol 3-kinase (PI3-K) is involved in the effect of apoptosis in B-CLL: association with protein kinase Cδ. Blood 2002; 100: 3741–3748.

    Article  CAS  PubMed  Google Scholar 

  6. Cuní S, Pérez-Aciego P, Pérez-Chacón G, Vargas JA, Sánchez A, Martín-Saavedra FM et al. A sustained activation of PI3K/NF-κB pathway is critical for the survival of chronic lymphocytic leukemia B cells. Leukemia 2004; 18: 1391–1400.

    Article  PubMed  Google Scholar 

  7. Furman RR, Asgary Z, Mascarenhas JO, Liou HC, Schattner EJ . Modulation of NF-κB activity and apoptosis in chronic lymphocytic leukemia B cells. J Immunol 2000; 164: 2200–2206.

    Article  CAS  PubMed  Google Scholar 

  8. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC . Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820–1828.

    CAS  PubMed  Google Scholar 

  9. Pepper C, Hoy T, Bentley DP . Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro and clinical drug resistance. Br J Cancer 1997; 76: 935–938.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Thomas A, El Rouby S, Reed JC, Krajewsky S, Silber R, Potmesil M et al. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 mutations and bcl-2/bax proteins in drug resistance. Oncogene 1996; 12: 1055–1062.

    CAS  PubMed  Google Scholar 

  11. Schriever F, Huhn D . New directions in the diagnosis and treatment of chronic lymphocytic leukaemia. Drugs 2003; 63: 953–969.

    Article  CAS  PubMed  Google Scholar 

  12. Ballard CE, Yu H, Wang B . Recent developments in depsipeptide research. Curr Med Chem 2002; 9: 471–498.

    Article  CAS  PubMed  Google Scholar 

  13. Khan SB, Maududi T, Barton K, Ayers J, Alkan S . Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma. Br J Haematol 2004; 125: 156–161.

    Article  CAS  PubMed  Google Scholar 

  14. Byrd JC, Shinn C, Ravi R, Willis CR, Waselenko JK, Flinn IW et al. Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 1999; 94: 1401–1408.

    CAS  PubMed  Google Scholar 

  15. Aron JL, Parthun MR, Marcucci G, Kitada S, Mone AP, Davis ME et al. Depsipeptide FR901228 induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein. Blood 2003; 102: 652–658.

    Article  CAS  PubMed  Google Scholar 

  16. Bar-Ness R, Avrahamy N, Matsuyama T, Rosenberg M . Increased cell surface hydrophobicity of a Serratia marcescens NS 38 mutant lacking wetting activity. J Bacteriol 1988; 170: 4361–4364.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Millet I, Phillips RJ, Sherwin RS, Ghosh S, Voll RE, Flavell RA et al. Inhibition of NF-κB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J Biol Chem 2000; 275: 15114–15121.

    Article  CAS  PubMed  Google Scholar 

  18. Cohen GM . Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1–16.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Kane LP, Shapiro VS, Stokoe D, Weiss A . Induction of NF-κB by the Akt/PKB kinase. Curr Biol 1999; 9: 601–604.

    Article  CAS  PubMed  Google Scholar 

  20. Madrid LV, Wang CY, Gurrtidge DC, Schottelius AJ, Baldwin Jr S, Mayo MW . Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 2000; 20: 1626–1638.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Yano O, Kanellopoulos J, Kieran M, Le Bail O, Israel A, Kourilsky P . Purification of KBF1, a common factor binding to both H-2 and beta 2-microglobulin enhancers. EMBO J 1987; 6: 3317–3324.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bellosillo B, Villamor N, Colomer D, Pons G, Montserrat E, Gil J . In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia. Blood 1999; 94: 2836–2843.

    CAS  PubMed  Google Scholar 

  23. De la Fuente MT, Casanova B, Cantero E, Hernández del Cerro M, García-Marco J, Silva A et al. Involvement of p53 in α4β1 integrin-mediated resistance of B-CLL cells to fludarabine. Biochem Biophys Res Comm 2003; 311: 708–712.

    Article  CAS  PubMed  Google Scholar 

  24. Jones DT, Ganeshaguru K, Virchis AE, Folarin NI, Lowdell MW, Mehta AB et al. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or γ radiation. Blood 2001; 98: 2800–2807.

    Article  CAS  PubMed  Google Scholar 

  25. Moon EY, Adam L . PDE4 inhibitors activate a mitochondrial apoptotic pathway in chronic lymphocytic leukemia cells that is regulated by protein phosphatase 2A. Blood 2003; 101: 4122–4130.

    Article  CAS  PubMed  Google Scholar 

  26. Decker T, Oelsner M, Kreitman RJ, Salvatore G, Wang Q-C, Pastan I et al. Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins. Blood 2004; 103: 2718–2726.

    Article  CAS  PubMed  Google Scholar 

  27. Campas C, López JM, Santidrián AF, Barragán M, Bellosillo B, Colomer D et al. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood 2003; 101: 3674–3680.

    Article  CAS  PubMed  Google Scholar 

  28. Lucas DM, Davis ME, Parthun MR, Mone AP, Kitada S, Cunningham KD et al. The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells. Leukemia 2004; 18: 1207–1214.

    Article  CAS  PubMed  Google Scholar 

  29. Jones DT, Ganeshaguru K, Anderson RJ, Jackson TR, Bruckdorfer KR, Low SY et al. Albumin activates the Akt signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil-and radiation-induced apoptosis. Blood 2003; 101: 3174–3180.

    Article  CAS  PubMed  Google Scholar 

  30. Kandel ES, Hay N . The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999; 253: 210–229.

    Article  CAS  PubMed  Google Scholar 

  31. Fecteau KA, Mei J, Wang H-CR . Differential modulation of signalling pathways and apoptosis of ras-transformed 10T1/2 cells by the depsipeptide FR901228. J Pharmacol Exp Ther 2002; 300: 890–899.

    Article  CAS  PubMed  Google Scholar 

  32. Burstein E, Duckett CS . Dying for NF-κB? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr Opin Cell Biol 2003; 15: 732–737.

    Article  CAS  PubMed  Google Scholar 

  33. Dewson G, Snowden RT, Almond JB, Dyer MJS, Cohen GM . Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 2003; 22: 2643–2654.

    Article  CAS  PubMed  Google Scholar 

  34. Yamaguchi H, Wang HG . The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 2001; 20: 7779–7786.

    Article  CAS  PubMed  Google Scholar 

  35. Tsuruta F, Masuyama N, Gotoh Y . The phosphatidylinositol 3-kinase (PI3-K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem 2002; 277: 14040–14047.

    Article  CAS  PubMed  Google Scholar 

  36. Senderowicz AM . Targeting cell cycle and apoptosis for the treatment of human malignancies. Curr Opin Cell Biol 2004; 16: 670–678.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the B-CLL patients who donated blood samples for this research and Dr Maria José Terol (Hospital Clínico, Valencia, Spain) for providing some of these samples. Drs Angel Corbí and José L Rodríguez-Fernández for valuable help and advice with the NF-κB studies and for reviewing the manuscript, and Dr Pedro Lastres for help with the flow cytometry analyses. This work was supported by grants 08.3/0030.1/2003 from the Comunidad Autónoma de Madrid, SAF2003-00824 from the Ministerio de Ciencia y Tecnología (MCyT), and 01/1183 from Fondo de Investigación Sanitaria (to AGP); and CIDEM Grant 301888 (Generalitat de Catalunya)/Fundació Bosch i Gimpera, to RPT). E Escobar and E López-Martín were supported by fellowships from MCyT.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Garcia-Pardo.

Additional information

Supplementary Information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Escobar-Díaz, E., López-Martín, E., Hernández del Cerro, M. et al. AT514, a cyclic depsipeptide from Serratia marcescens, induces apoptosis of B-chronic lymphocytic leukemia cells: interference with the Akt/NF-κB survival pathway. Leukemia 19, 572–579 (2005). https://doi.org/10.1038/sj.leu.2403679

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403679

Keywords

This article is cited by

Search

Quick links